Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Enabling precision medicine via standard communication of HTS provenance, analysis, and results.

Alterovitz G, Dean D, Goble C, Crusoe MR, Soiland-Reyes S, Bell A, Hayes A, Suresh A, Purkayastha A, King CH, Taylor D, Johanson E, Thompson EE, Donaldson E, Morizono H, Tsang H, Vora JK, Goecks J, Yao J, Almeida JS, Keeney J, Addepalli K, Krampis K, Smith KM, Guo L, Walderhaug M, Schito M, Ezewudo M, Guimera N, Walsh P, Kahsay R, Gottipati S, Rodwell TC, Bloom T, Lai Y, Simonyan V, Mazumder R.

PLoS Biol. 2018 Dec 31;16(12):e3000099. doi: 10.1371/journal.pbio.3000099. eCollection 2018 Dec.

2.

An Inter-regional US Blood Supply Simulation Model to Evaluate Blood Availability to Support Planning for Emergency Preparedness and Medical Countermeasures.

Simonetti A, Ezzeldin H, Walderhaug M, Anderson SA, Forshee RA.

Disaster Med Public Health Prep. 2018 Apr;12(2):201-210. doi: 10.1017/dmp.2017.48. Epub 2017 Aug 23.

PMID:
28831947
3.

Natural language processing systems for capturing and standardizing unstructured clinical information: A systematic review.

Kreimeyer K, Foster M, Pandey A, Arya N, Halford G, Jones SF, Forshee R, Walderhaug M, Botsis T.

J Biomed Inform. 2017 Sep;73:14-29. doi: 10.1016/j.jbi.2017.07.012. Epub 2017 Jul 17. Review.

4.

Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts.

Pierce CE, Bouri K, Pamer C, Proestel S, Rodriguez HW, Van Le H, Freifeld CC, Brownstein JS, Walderhaug M, Edwards IR, Dasgupta N.

Drug Saf. 2017 Apr;40(4):317-331. doi: 10.1007/s40264-016-0491-0.

5.

Decision support environment for medical product safety surveillance.

Botsis T, Jankosky C, Arya D, Kreimeyer K, Foster M, Pandey A, Wang W, Zhang G, Forshee R, Goud R, Menschik D, Walderhaug M, Woo EJ, Scott J.

J Biomed Inform. 2016 Dec;64:354-362. doi: 10.1016/j.jbi.2016.07.023. Epub 2016 Jul 28.

6.

Babesiosis Occurrence among the Elderly in the United States, as Recorded in Large Medicare Databases during 2006-2013.

Menis M, Forshee RA, Kumar S, McKean S, Warnock R, Izurieta HS, Gondalia R, Johnson C, Mintz PD, Walderhaug MO, Worrall CM, Kelman JA, Anderson SA.

PLoS One. 2015 Oct 15;10(10):e0140332. doi: 10.1371/journal.pone.0140332. eCollection 2015.

7.

A comparative pharmacokinetic estimate of mercury in U.S. Infants following yearly exposures to inactivated influenza vaccines containing thimerosal.

Mitkus RJ, King DB, Walderhaug MO, Forshee RA.

Risk Anal. 2014 Apr;34(4):735-50. doi: 10.1111/risa.12124. Epub 2013 Oct 10.

PMID:
24117921
8.

A stock-and-flow simulation model of the US blood supply.

Simonetti A, Forshee RA, Anderson SA, Walderhaug M.

Transfusion. 2014 Mar;54(3 Pt 2):828-38. doi: 10.1111/trf.12392. Epub 2013 Aug 29.

PMID:
23992403
9.

Advancing risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop.

Gallagher LM, Ganz PR, Yang H, Kessler DA, O'Brien SF, Custer BS, Busch MP, Dodd RY, Stramer SL, Walderhaug MO, Forshee RA, Williams AE, Epstein JS, Anderson SA.

Transfusion. 2013 Feb;53(2):455-63. doi: 10.1111/j.1537-2995.2012.03808.x. Epub 2012 Jul 31. No abstract available.

PMID:
22845334
10.

Babesiosis among elderly Medicare beneficiaries, United States, 2006-2008.

Menis M, Anderson SA, Izurieta HS, Kumar S, Burwen DR, Gibbs J, Kropp G, Erten T, Macurdy TE, Worrall CM, Kelman JA, Walderhaug MO.

Emerg Infect Dis. 2012 Jan;18(1):128-31. doi: 10.3201/eid1801.110305.

11.

Updated aluminum pharmacokinetics following infant exposures through diet and vaccination.

Mitkus RJ, King DB, Hess MA, Forshee RA, Walderhaug MO.

Vaccine. 2011 Nov 28;29(51):9538-43. doi: 10.1016/j.vaccine.2011.09.124. Epub 2011 Oct 11.

PMID:
22001122
12.

Statistical, epidemiological, and risk-assessment approaches to evaluating safety of vaccines throughout the life cycle at the Food and Drug Administration.

Ball R, Horne D, Izurieta H, Sutherland A, Walderhaug M, Hsu H.

Pediatrics. 2011 May;127 Suppl 1:S31-8. doi: 10.1542/peds.2010-1722F. Epub 2011 Apr 18. Review.

PMID:
21502249
13.

FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety.

Atreya C, Nakhasi H, Mied P, Epstein J, Hughes J, Gwinn M, Kleinman S, Dodd R, Stramer S, Walderhaug M, Ganz P, Goodrich R, Tibbetts C, Asher D.

Transfusion. 2011 Aug;51(8):1855-71. doi: 10.1111/j.1537-2995.2011.03084.x. Epub 2011 Mar 10. No abstract available.

PMID:
21392016
14.

Risk assessment and cost-effectiveness/utility analysis.

Busch M, Walderhaug M, Custer B, Allain JP, Reddy R, McDonough B.

Biologicals. 2009 Apr;37(2):78-87. doi: 10.1016/j.biologicals.2009.01.007. Epub 2009 Feb 24. Review.

PMID:
19243972
15.

Recurrent multistate outbreak of Salmonella Newport associated with tomatoes from contaminated fields, 2005.

Greene SK, Daly ER, Talbot EA, Demma LJ, Holzbauer S, Patel NJ, Hill TA, Walderhaug MO, Hoekstra RM, Lynch MF, Painter JA.

Epidemiol Infect. 2008 Feb;136(2):157-65. Epub 2007 May 16.

16.

Potential for internalization, growth, and survival of Salmonella and Escherichia coli O157:H7 in oranges.

Eblen BS, Walderhaug MO, Edelson-Mammel S, Chirtel SJ, De Jesus A, Merker RI, Buchanan RL, Miller AJ.

J Food Prot. 2004 Aug;67(8):1578-84.

PMID:
15330518
17.
18.

Purification and kinetic characterization of the Kdp-ATPase.

Naprstek J, Walderhaug MO, Epstein W.

Ann N Y Acad Sci. 1992 Nov 30;671:481-3. No abstract available.

PMID:
1288346
19.

KdpD and KdpE, proteins that control expression of the kdpABC operon, are members of the two-component sensor-effector class of regulators.

Walderhaug MO, Polarek JW, Voelkner P, Daniel JM, Hesse JE, Altendorf K, Epstein W.

J Bacteriol. 1992 Apr;174(7):2152-9.

20.

Gene regulation of plasmid- and chromosome-determined inorganic ion transport in bacteria.

Silver S, Walderhaug M.

Microbiol Rev. 1992 Mar;56(1):195-228. Review.

21.

The bacterial Kdp K(+)-ATPase and its relation to other transport ATPases, such as the Na+/K(+)- and Ca2(+)-ATPases in higher organisms.

Epstein W, Walderhaug MO, Polarek JW, Hesse JE, Dorus E, Daniel JM.

Philos Trans R Soc Lond B Biol Sci. 1990 Jan 30;326(1236):479-86; discussion 486-7. Review.

PMID:
1970651
22.

Wide distribution of homologs of Escherichia coli Kdp K+-ATPase among gram-negative bacteria.

Walderhaug MO, Litwack ED, Epstein W.

J Bacteriol. 1989 Feb;171(2):1192-5.

23.

Genetics of Kdp, the K+-transport ATPase of Escherichia coli.

Polarek JW, Walderhaug MO, Epstein W.

Methods Enzymol. 1988;157:655-67. No abstract available.

PMID:
2976470
24.

Structural relatedness of three ion-transport adenosine triphosphatases around their active sites of phosphorylation.

Walderhaug MO, Post RL, Saccomani G, Leonard RT, Briskin DP.

J Biol Chem. 1985 Mar 25;260(6):3852-9.

25.

6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase from rat liver.

Pilkis SJ, Walderhaug M, Murray K, Beth A, Venkataramu SD, Pilkis J, El-Maghrabi MR.

J Biol Chem. 1983 May 25;258(10):6135-41.

Supplemental Content

Loading ...
Support Center